复星医药(02196.HK)首席财务官变更

阿斯达克财经
Apr 08

复星医药(02196.HK) 公布,董事会收到陈战宇的书面辞职函,因工作安排调整,陈战宇申请辞去首席财务官职务,已自4月2日生效。辞任生效后,陈战宇仍将继续担任资深副总裁职务。同日,经首席执行官提名,董事会同意聘任黄智为高级副总裁、首席财务官,任期至董事会任期届满之日止。(sl/w)(港股报价延迟最少十五分钟。沽空资料截至 2026-04-02 16:25。)AASTOCKS新闻

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10